Watch the Webinar Series:

Advancing Pathways for the Development of Innovative Therapies for Children With Inflammatory Bowel Disease

Inflammatory bowel disease (IBD) is common enough that most hospital and community-based pediatricians will have to take care of children with some type of IBD. Addressing the needs of children with IBD related to drug development across stakeholders has emerged as a very important medical topic. Watch our webinar recordings to learn from our experts.

View the forum recordings to learn more about:

  • Developing solutions to advance pathways for regulatory approval and labeling of IBD therapies for use in children
  • Gaining perspective and exploring solutions through discussions with patients and families, clinicians, pharmaceutical sponsors and regulators
  • Identifying gaps in knowledge that impact the development process and explore actionable items to address these gaps

What Attendees Are Saying:

“Very eye-opening presentation. Loved hearing from the patient and family advocates too!”

“Outstanding content and speakers.”

“Fabulous meeting — very relevant and important discussion; scientific based high-quality presentations!”

“Thank you for bringing together this amazing group of expert colleagues. Really looking forward to hearing how these sessions will translate into other collaborations!”

Watch the Virtual Public Webinar Series Hosted by I-ACT for Children

Real-World Data (RWD)/Real-World Evidence (RWE), Biomarkers & Endpoints

Data Extrapolation

Perspectives: Patient, Family and Healthcare Providers

Clinical Trial Designs and relevant discussion points from the previous three webinars

This Forum has been supported in part by a grant from the US Food and Drug Administration (award #5Y18FD006297), in addition to educational grants received from Eli Lilly and Company, Janssen Research & Development LLC and the Pharmaceutical Research and Manufacturers of America.